(Q39176157)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

A case study of personalized therapy for osteosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Bernard Séguin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Lara E Davis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Nicolle E Hofmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Guangheng Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Elaine T Huang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Marc M Loriaux

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Shay Bracha

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Stuart C Helfand

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

John E Mata

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Kevin Marley

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Atiya Mansoor

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jinu Abraham

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Charles Keller

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

22 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

published in

Pediatric Blood Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

1313-1319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23526721%20AND%20SRC:MED&resulttype=core&format=json

A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors

27 February 2020

cites work

1 reference

Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer

21 January 2018

1 reference

A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors.

21 January 2018

1 reference

Cross talk from pets to people: translational osteosarcoma treatments

21 January 2018

1 reference

Rb1 gene inactivation expands satellite cell and postnatal myoblast pools

21 January 2018

1 reference

The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability

21 January 2018

1 reference

Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium

21 January 2018

1 reference

ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells

21 January 2018

1 reference